Angiogenesis
Angiogenesis — The physiological process of forming new blood vessels from pre-existing vasculature, a key area of investigation in peptide-based tissue repair research.
What Is Angiogenesis?
Angiogenesis is the formation of new blood vessels from pre-existing vasculature. It is essential for wound healing, tissue regeneration, and embryonic development, but pathological angiogenesis drives tumor growth and diabetic retinopathy. Multiple research peptides modulate angiogenesis, making it a central therapeutic target.
Pro-Angiogenic Peptides
- BPC-157: Promotes angiogenesis via VEGF upregulation and endothelial cell migration
- GHK-Cu: Stimulates VEGF and FGF expression, promoting new vessel formation
- TB-500: Promotes endothelial cell migration and tube formation
- LL-37: Promotes angiogenesis through EGFR and formyl peptide receptor transactivation
Anti-Angiogenic Peptides
Endostatin, angiostatin, and cyclic RGD peptides (cilengitide) inhibit tumor angiogenesis by blocking integrin-mediated endothelial cell adhesion and migration.
Frequently Asked Questions
What is Angiogenesis?
The physiological process of forming new blood vessels from pre-existing vasculature, a key area of investigation in peptide-based tissue repair research.
Why is Angiogenesis important in peptide research?
Angiogenesis is a fundamental concept in biology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.